Accurate phosphorylation of tyrosine residues in proteins plays a central role in regulation of cellular function. Although connections between aberrant tyrosine kinase activity and malignancy are well-established, signi®cantly less is known about the roles of protein tyrosine phosphatases (PTPases) in tumorigenesis. We have previously shown that the transmembranal form of PTPase Epsilon (PTPe) is upregulated in mouse mammary tumors initiated speci®cally by ras or neu, suggesting that PTPe may play a role in transformation by these two oncogenes. In order to test this notion in vivo, we created transgenic mice that express elevated levels of PTPe in their mammary epithelium by use of the MMTV promoter/enhancer. Following several cycles of pregnancy female MMTV-PTPe mice uniformly developed pronounced and persistent mammary hyperplasia which was accompanied by residual milk production. Solitary mammary tumors were often detected secondary to mammary hyperplasia. The sporadic nature of the tumors, the long latency period prior to their development, and low levels of transgene expression in the tumors indicate that PTPe provides a necessary, but insucient, signal for oncogenesis. The results provide genetic evidence that PTPe plays an accessory role in production of mammary tumors in a manner consistent with its upregulation in mammary tumors induced by ras or neu.
Introduction
Reversible phosphorylation of tyrosine residues in proteins plays a critical role in regulation of nearly all processes which occur in living cells and organisms. Tyrosine phosphorylation of proteins can aect their structure, thereby altering their function, their ability to associate with other proteins, and possibly their subcellular localization. The importance of accurate tyrosine phosphorylation is further underscored by the realization that many transforming oncogenes are tyrosine kinases (PTKs). It is therefore not surprising that tyrosine phosphorylation is tightly controlled, both at the phosphorylation and at the dephosphorylation levels (Sun and Tonks, 1994; Hunter, 1995) .
Tyrosine dephosphorylation is regulated by protein tyrosine phosphatases (PTPases), a large family of enzymes which are distinct from PTKs (reviewed Barford et al., 1995; Tonks and Neel, 1996) . PTPases are a structurally diverse family of transmembranal, receptor-like and non-transmembranal, cytoplasmic enzymes, of which several dozen individual members have been identi®ed in organisms ranging from viruses to man. Transmembranal PTPases typically contain two catalytic domains each and are believed to bind extracellular molecules and to participate in transduction of signals into cells. Cytoplasmic PTPases generally contain a single catalytic domain¯anked by protein domains, which either regulate the catalytic activity of the molecule (Barford and Neel, 1998; Hao et al., 1997) or target it to particular regions within the cell (Mauro and Dixon, 1994) . PTPases of this class, generally those containing SH2 domains, have been found associated with receptor-type PTKs as well as with receptors devoid of PTK activity. Depending on their context, associations of this type can enhance or decrease the intensity of the transduced signal and are physiologically signi®cant (Tonks and Neel, 1996; Frearson and Alexander, 1997; Neel and Tonks, 1997) .
As many oncogenes possess tyrosine kinase activity, PTPase activity could be expected to have antioncogenic properties. Signi®cant data has been published in agreement with this, including reports linking enhanced activity of speci®c PTPases with reduction in cell transformation in culture (Zhai et al., 1995; Cao et al., 1998; Shin et al., 1997; Liu et al., 1998) . Recently, a human tumor suppressor gene at chromosome 10q23 was identi®ed as the PTPase/lipid phosphatase PTEN/MMAC1 Steck et al., 1997; Myers et al., 1997; Maehama and Dixon, 1998) . Other reports have shown that speci®c PTPases can transform cultured cells, as in the cases of the cellcycle regulating molecule CDC25 (Galaktionov et al., 1995) and the transmembranal PTPase Alpha (Zheng et al., 1992) . We have suggested that a connection exists in vivo between expression of the transmembranal form of PTPase Epsilon (tm-PTPe) and transformation of mammary epithelial cells by ras or neu (Elson and Leder, 1995a; see below) . Together, these data indicate that tyrosine dephosphorylation is central to the processes of malignant transformation, although the nature and precise details of this involvement remain to be elucidated for each PTPase.
In order to study the involvement of PTPases in the genesis of breast cancer we turned to lines of transgenic mice which develop mammary tumors due to breastspeci®c expression of oncogenes directed by the mouse mammary tumor virus (MMTV) promoter (Sinn et al., 1987; Muller et al., 1988) . Tumors arising in this system are well-controlled, in that the main molecular event which initiates them (i.e., overexpression of a particular oncogene) is de®ned, and all tumors arise in the same inbred genetic background (FVB/N). Examination of mammary tumors of MMTV-oncogene mice revealed that the receptor type, transmembranal form of protein tyrosine phosphatase Epsilon (tm-PTPe) is expressed speci®cally in tumors initiated by ras or neu, but not in similar tumors initiated by myc, int-2, heregulin, or TGF-a (Elson and Leder, 1995a; A Elson, unpublished results) . Furthermore, expression of tmPTPe in murine tumors initiated by ras is at least partially breast-speci®c and was not observed in a rasbased uterine tumor or in several ras-based fibrosarcomas (Elson and Leder, 1995a) . This ®nding suggests that upregulation of PTPe expression may be one of the molecular events which participate in transformation of mammary epithelial cells by ras or neu. Of note, the structurally-and physiologically-distinct cytoplasmic form of PTPe (Elson and Leder, 1995b) has not been implicated thus far in mammary transformation.
We next asked how central tm-PTPe is to the transformation process in vivo. In order to address this issue from a genetic perspective, we generated transgenic mice in which the MMTV promoter drives expression of tm-PTPe to the mammary epithelium. We report here that expression of MMTV-PTPe in mice is associated with mammary gland hyperplasia and with an increased incidence of mammary tumors in female mice. The data indicate that PTPe is not a potent transforming agent. However, PTPe does act to promote, rather than inhibit, transformation of mammary epithelial cells in a manner consistent with this PTPase playing an accessory role in mammary gland transformation by ras or neu.
Results

Generation of MMTV-PTPe transgenic mice
In order to assess the ability of tm-PTPe to transform mammary epithelial cells in vivo, we constructed transgenic mice in which expression of the tm-PTPe cDNA is directed to the mammary epithelium by the MMTV promoter (Figure 1a ). Pronuclear microinjection of the MMTV-tm-PTPe-SV40 PolyA fusion gene yielded a number of mice which had integrated the transgene into their genomes and subsequently transmitted it to their ospring in Mendelian fashion. Two of the founder mice (numbers 410 and 414, Figure  1b) were expanded into lines. Results obtained with both lines are similar, and we detail the results obtained with line 410.
Examination of mRNA from several organs of MMTV-PTPe transgenic mice revealed two prominent mRNA bands not observed in non-transgenic mice (Figure 1c ). Both bands diered in size from endogenous PTPe mRNA and were expressed several fold more intensely than the endogenous message ( Figure 1c and Elson and Leder, 1995a) . Taken together, the data indicate that these bands represent transgenic mRNA. Examination of MMTV-PTPe mRNA expression revealed that the transgene is expressed in the salivary glands and in the mammary glands of pregnant or lactating, but not virgin, transgenic mice, and is not expressed in mammary glands of a pregnant female mouse from a nonexpressing transgenic line (Figure 1c ). This expression pattern is typical of the hormonally-regulated MMTV promoter (Stewart et al., 1984; Muller et al., 1988; Kitsberg and Leder, 1996; Krane and Leder, 1996) . No expression of the transgene was observed in the lachrymatory Harderian gland, a site where MMTVbased transgenes are occasionally expressed (Sinn et al., 1987; Krane and Leder, 1996) . Protein blot analysis of mammary glands of pregnant MMTV-PTPe transgenic mice revealed the presence of a transgenederived full-length tm-PTPe protein of *105 kDa, as well as a PTPe-derived protein of *70 kDa ( Figure  1d ). Both proteins are also detected in extracts of mouse mammary tumors initiated by ras or neu (Elson and Leder, 1995a) , indicating that the transgene results in correct PTPe protein expression. Overall, transgenic tm-PTPe is expressed at levels higher than those of endogenous tm-PTPe but similar to those of mammary tumors (Elson and Leder, 1995a) . In situ RNA analysis revealed that MMTV-PTPe mRNA was expressed speci®cally in mammary epithelial cells. Probing samples of glands obtained from pregnant transgenic mice with an anti-sense probe for PTPe yielded a strong signal localized exclusively in the epithelial components of the gland (Figure 2d ). In contrast, the signal observed in mammary glands of a pregnant wild-type mouse was nearly undetectable (Figure 2b ). Of note, light-®eld examination of the same tissue sections revealed that not all epithelial cells expressed the transgene to similar extents ( Figure 2c ). Non-uniform expression of transgenes in mammary glands is a common observation (Stamp et al., 1992; Faerman et al., 1995; Krane and Leder, 1996) . This phenomenon is not well understood, and may re¯ect dierences in the function or physiological state of adjacent cells at the time of tissue harvest.
MMTV-PTPe expression is associated with mammary gland hyperplasia
Female MMTV-PTPe mice gave birth to pups and were able to nurse them without obvious diculties. However, observation of transgenic mice which had been bred continuously to maximize transgene expression revealed improper mammary gland regression. This ®nding was most evident when mammary glands of transgenic mice which had undergone 3 ± 4 pregnancies were examined by whole-mount analysis, 6 ± 8 months after weaning of the last litter ( Figure 3b ). The degree of residual mammary epithelial development observed under these conditions was striking, with copious amounts of developed secondary and tertiary ducts and lobules clearly evident. Of note, hyperplastic mammary tissue expressed the tm-PTPe transgene ( Figure 4a ). Although somewhat variable in the degree of residual development, mammary glands from wild-type, control mice of similar reproductive histories were typically well-regressed and contained sparse epithelial trees ( Figure 3a) .
Histologic examination of sections prepared from hyperplastic glands of MMTV-PTPe transgenic mice revealed large amounts of epithelial structures; multiple foci of metaplasia, dysplasia, ®brosis, and inflammation were routinely observed ( Figure 3d ). These ®ndings were seen in mammary glands from each retired breeder female mouse of lines 410 and 414 examined. On occasion, foci of neoplastic cells were observed in glands from transgenic mice as will be elaborated upon below. Mammary glands of control, wild-type female mice matched for age and reproductive history were free of such pathologies (Figure 3c ), (a) Transgene-derived RNA is expressed in hyperplastic mammary glands of transgenic mice (MMTVPTPe), but not in quiescent mammary glands of non-transgenic (WT) mice. Arrows mark the positions at which transgenic (Tg) and endogenous (WT) PTPe mRNA migrate. (b) Hyperplastic mammary glands of transgenic mice (MMTV-PTPe) express higher levels of b-casein RNA than well-regressed glands from wild-type (WT) mice. Each lane contains 10 micrograms of total RNA; equal loading is documented by ethidium bromide stain of 28S RNA on blot as were glands from 16 month-old virgin transgenic mice (not shown). The severity of the hyperplastic phenotype is then correlated with pregnancy and with the associated massive expression of the hormonallyregulated MMTV-PTPe transgene. Similar links between pregnancy and phenotype severity have often been observed in other MMTV-based transgenic mice lines (c.f. Kitsberg and Leder, 1996; Krane and Leder, 1996) .
Further examination of hyperplastic mammary tissue from MMTV-PTPe mice revealed that the glands contained signi®cant amounts of milk, although the mice had not been nursing pups for well over half a year. In agreement, hyperplastic glands from transgenic mice expressed b-casein mRNA at levels signi®cantly higher than glands obtained from wild-type mice of similar reproductive histories ( Figure  4b ). Once established, hyperplasia and milk production persisted throughout the life of MMTV-PTPe mice, and were found also in transgenic mice which had not been nursing pups for well over a year. Overall, these data indicate that mammary glands of MMTV-PTPe mice fail to regress normally and remain in a partiallyactivated state in a manner linked to transgene expression.
MMTV-PTPe female mice are prone to develop mammary tumors
In order to determine whether tm-PTPe can transform mammary epithelial cells in vivo, kinetics of tumor development were determined in 12 MMTV-PTPe and 12 wild-type female mice. Mice of both groups were allowed to mate at will and nurse pups freely in order to maximize expression of the MMTV-PTPe transgene in mice which carried it. Following 3 ± 4 cycles of pregnancy and lactation, male mice were removed and female mice were examined twice weekly for the presence of tumors.
MMTV-PTPe transgenic mice developed mammary tumors at a rate signi®cantly higher than control mice. The earliest tumors of MMTV-PTPe mice appeared at 260 days; by 630 days, 67% (8/12) of transgenics had developed tumors, compared with 17% (2/12) of control mice ( Figure 5 ). Tumors of transgenic mice arose in glands which were otherwise markedly hyperplastic and contained pre-malignant lesions in addition to the tumors themselves. Similar lesions were observed in mammary glands of the four transgenic mice which had not developed palpable tumors at the time the experiment was terminated. Of note, wildtype, non-transgenic FVB/N mice have very low levels of spontaneous mammary tumors ( Figure 5 ).
Histologic examination of the tumors revealed that they were typically adenocarcinomas, comprised of transformed epithelial cells arranged as densely-packed clusters with some squamous dierentiation and keratinization ( Figure 6 ). The appearance of these tumors was typically distinct from that of other MMTV-oncogene-based mammary tumors and from the two tumors which arose in the wild-type control mice used in this study (R Cardi, personal communication) . In many cases, the epithelial-based tumors were surrounded by or mixed with dense regions of spindle-shaped, sarcoma-like cells ( Figure 6a) ; spindleshaped cells were not found in tumors from the two wild-type mice included in this study (not shown). Both classes of cells could be isolated from tumor tissue and were established separately in culture. Separate injections of cultured epithelial-or spindle-shaped tumor cells into¯anks or mammary fat pads of syngeneic wild-type female mice resulted in the appearance of tumors at the sites of injection. Other than appearance of tumors, injection of tumor cells into wild-type mammary glands did not induce changes in the structure of these glands as judged by histologic or whole-mount analyses (not shown). These ®ndings indicate that both populations of epithelial-and spindle-shaped cells found in the tumors were in fact transformed. Tumors containing both types of cells were therefore not a mixture of transformed and nontransformed, entrapped cells, nor did they result from one transformed cell type interacting with and promoting growth of adjacent non-transformed cells. Extensive and repeated associations found between epithelial-and spindle-shaped tumor cells imply that both arise in the same transformation event and suggest that one cell type is the precursor of the other. This observation is consistent with epithelial-tomesenchymal transition (EMT, Birchmeier et al., 1996) , a process which is one of the characteristics of advanced tumors of epithelial origin. Figure 5 Tumor-free survival of non-transgenic vs MMTV-PTPe transgenic female mice. Mice were allowed to mate and nurse pups freely, and were examined twice weekly for presence of tumors. Tumors were detected as either visible or palpitatable masses; all were subsequently veri®ed by histologic examination In addition to mammary gland hyperplasia and mammary tumors, many MMTV-PTPe mice exhibited abnormalities in their myeloid cell series. These ®ndings ranged from mildly hyperplastic spleens to what appeared to be by histologic examination fullblown myeloid leukemia involving the liver and kidneys. However, none of these cell growths could be established in culture, nor did they establish themselves when injected directly into syngeneic mice. Furthermore, injection of mammary tumor cells into syngeneic mice often resulted in expansion of the myeloid series in spleens of the host, wild-type mice. Myeloid abnormalities of MMTV-PTPe mice are most likely an event secondary to the presence of the mammary tumors, and are probably not directly attributable to inherent properties of tm-PTPe.
PTPe is not capable of directly transforming mammary epithelial cells
Despite the appearance of mammary tumors in MMTV-PTPe mice, several characteristics of these tumors indicate that tm-PTPe overexpression is not their sole cause. MMTV-PTPe tumors were sporadic, with typically one to three tumors observed per mouse. As tumors arose in glands which were hyperplastic and in which many epithelial cells expressed tm-PTPe (Figure 2c, d) , additional molecular events are clearly required for transformation of a small fraction of these cells. This conclusion is further strengthened by the relatively long latency period before tumors are detected in MMTV-PTPe mice ( Figure 5 ). Of note, this result is typical of tumors initiated by transgenes in mice.
Most tumors in which transgene expression was examined expressed the transgene weakly, if at all. A total of seven tumors from six mice were analysed for transgene expression by RNA blot analysis. Figure 7 documents PTPe expression levels in three of the tumors; the other four tumors did not express the transgene (not shown). Low expression of MMTVPTPe is not due to loss of the transgene, as examination of DNA from several independent tumors revealed that all had retained the transgene and had not rearranged it in an obvious manner (not shown). This ®nding indicates that expression of tmPTPe is not required for maintenance of the transformed tumor phenotype, although it does not strictly rule out a possible direct role for tm-PTPe in tumor initiation. As discussed below, we believe that tm-PTPe plays a subtle role in enhancing mammary tumorigenesis by promoting mammary hyperplasia, thereby increasing the chances of sporadic transformation events beyond what is observed in wild-type mice.
Discussion
The important roles PTPases play in regulating tyrosine phosphorylation suggest that some members of this gene family can either promote or impede malignant transformation. In the course of our previous studies we had shown that the transmembranal form of PTPe is overexpressed in murine mammary tumors initiated speci®cally by either ras or neu (Elson and Leder, 1995a) . As this ®nding could link tm-PTPe to processes by which ras or neu transform mammary epithelial cells, we set out to examine the eects of in vivo overexpression of tmPTPe on mouse mammary glands.
Although able to nurse pups in an apparently normal manner, MMTV-PTPe female transgenic mice developed severe mammary gland hyperplasia following several cycles of pregnancy and lactation. Examination of MMTV-PTPe mammary glands several months following weaning of the last litter of pups revealed signi®cant residual mammary development accompanied by milk production. Of note, hyperplastic mammary glands were less developed than glands of actively nursing mice, with the latter containing more epithelial tissue, producing more milk, and expressing higher levels of b-casein. This ®nding is likely the result of PTPe not being able to sustain peak gland development, as well as of the non-uniform expression of the transgene in mammary epithelium (Figure 2c) .
Hyperplasia was observed in all ten mammary glands of each MMTV-PTPe female mouse examined, whereas it was rarely encountered in wild-type control mice of similar reproductive histories. This ®nding clearly indicates that mammary hyperplasia and transgene expression are linked, although the precise molecular basis for this linkage remains to be determined. Persistence of mammary epithelial cells in glands of MMTV-PTPe mice is consistent with tmPTPe either providing a growth-stimulatory signal or preventing mammary gland regression, possibly by hampering apoptosis which is required for regression to occur (Quarrie et al., 1996) . The demonstrated association between tm-PTPe and the adaptor molecule Grb2 in ras-and neu-based mammary tumors (Toledano-Katchalski and Elson, in press) can provide a starting point for further molecular-level studies of this issue. Histologic examination of hyperplastic MMTVPTPe mammary glands revealed multiple foci of ®brosis, in¯ammation, dysplasia, and on occasion frank neoplasia. In agreement with this ®nding, mammary tumors were observed in MMTV-PTPe mice at a frequency signi®cantly higher than in wildtype mice of similar reproductive histories ( Figure 5) . However, the sporadic nature of the tumors and the relatively long latency period prior to their detection argue that overexpression of tm-PTPe is not sucient for transformation. With the exception of activated neu (Muller et al., 1988) , expression of most oncogenes in mouse mammary glands causes sporadic tumors, indicating that overexpressing a single oncogene is typically insucient for transformation (Sinn et al., 1987; Muller et al., 1990) . ras, neu, and similarly powerful oncogenes can cause mammary tumors in mice within 2 ± 3 months (Muller et al., 1988; Sinn et al., 1987) , while weaker oncogenes, such as int-2 (Muller et al., 1990) or neuregulin (Krane and Leder, 1996) require more time. The tumorigenic phenotype of MMTV-PTPe mice is therefore relatively weak.
Interestingly, mammary tumors of MMTV-PTPe mice express either low or undetectable levels of the transgene, as judged by RNA blotting, although the transgene has not been lost or grossly rearranged in these tumors. Similar results are occasionally observed in tumors of transgenic mice (Seldin and Leder, 1995) . These results indicate that expression of tm-PTPe is not strictly required for maintenance of the transformed phenotype, and can be accounted for by a`hit and run' mechanism of tumorigenesis. The data are also consistent with PTPe indirectly promoting, instead of actively participating in, the transformation process. Transgene-associated mammary hyperplasia could enhance tumorigenesis indirectly by providing significantly more epithelial cells as targets for sporadic transformation events than found in wild-type mice. We favor this second, more straightforward model as it agrees with the relatively weak tumor phenotype of MMTV-PTPe mice.
The results presented here suggest that the MMTVPTPe transgene acts indirectly to increase the frequency of transformation of mammary epithelial cells, but that the transformation process is inherently stochastic. Why then does histopathological examination reveal dierences between MMTV-PTPe mammary tumors and the two tumors which arose in wild-type control mice included in this study? Non-uniform expression of MMTV-based transgenes in mammary epithelium (Figure 2 ) likely means that the resulting hyperplasia originates in selected populations of mammary epithelial cells. This selection step, which is absent from wild-type mice, may in¯uence the properties of the resulting tumors.
Mammary tumors of MMTV-PTPe mice were typically composed of transformed epithelial and spindle-shaped cells, in a manner not typical of other MMTV-oncogene tumors. Close and repeated association between these two transformed cell types in single tumors suggests that both are part of the tumorigenic phenotype of MMTV-PTPe mice. Of note, the MMTV promoter is expressed in epithelial cells and it is in this cell compartment that pre-malignant hyperplasia occurs. It is therefore tempting to speculate that the spindle-like cells develop from the transformed epithelial cells. Transformations of this type have been documented before; epithelial cells are well known to lose their characteristic morphology on occasion and to acquire mesenchymal properties, among them spindle-like form. This process, termed EMT (epithelial-to-mesenchymal transition), has been documented in well-advanced epithelial tumors and is correlated with increases in metastatic potential (reviewed in Birchmeier et al., 1996) . EMT of mammary epithelial cells can be caused by several factors, among them expression of growth factors (Miettinen et al., 1994; Solic and Davies, 1997) , transcription factors (Gilles et al., 1997; Savagner et al., 1997) , or matrix metallo-proteases (Lochter et al., 1997; Ahmad et al., 1998) .
The data presented here argue that overexpression of tm-PTPe is associated with mammary gland hyperplasia in mice and with an increased tendency for developing mammary tumors. We have demonstrated that tm-PTPe is not a potent transforming agent in its own right. Therefore, although it is expressed speci®cally in mammary tumors initiated by ras or neu (Elson and Leder, 1995a) , tm-PTPe is not the sole mediator of transformation by either oncogene. The results provide genetic evidence that tm-PTPe plays an accessory role in production, rather than inhibition, of mammary tumorigenesis in a manner consistent with its upregulation in mammary tumors induced by ras or by neu.
Materials and methods
Transgene construction and generation of transgenic mice tm-PTPe clone #25 was isolated from a cDNA library prepared from AC816 cells, a ras-based murine mammary tumor cell line (Elson and Leder, 1995a) . The sequence of this clone was identical to that of PTPe from nontransformed sources. Clone 25 was digested with SmaI and XhoI, liberating a fragment which contained the entire 2099 bp coding region of tm-PTPe, plus 89 bp and 62 bp of 5'-and 3'-untranslated regions, respectively. The cDNA fragment was blunted and cloned into the previously-blunted EcoRI site of a plasmid cassette containing the MMTV LTR and SV40 splicing and polyadenylation sites (Muller et al., 1988) . Correct orientation of the insert was veri®ed by restriction analysis.
The DNA fragment used for microinjection was freed of vector sequences by digestion with SalI and SpeI. Following agarose gel puri®cation and electroelution from the gel matrix, the DNA was phenol extracted, precipitated, and resuspended in injection buer (0.15 M KCl, 5 mM NaCl, 10 mM PIPES, pH 7.0) at a ®nal concentration of 5 ng/ml. Approximately 2 pl were injected into male pronuclei of fertilized FVB/N eggs. Viable embryos were then implanted into oviducts of pseudopregnant Swiss-Webster mice and allowed to develop to term.
Identi®cation of transgenic animals
DNA was prepared from tail samples of mice by the proteinase K method, digested with BamHI, electrophoresed through 1% agarose gels, blotted onto GeneScreen membranes (New England Nuclear, Boston MA, USA), and hybridized as described in Ausubel et al. (1994) . The probe used for hybridization was the entire transgene fragment used for microinjection. Following hybridization at 428, blots were rinsed at room temperature in 1% SDS, 26SSC (16SSC is 0.15 M NaCl, 0.015 M Na Citrate), washed at 608 in 1% SDS, 0.16SSC, and exposed to ®lm. DNA samples of all mice contained two bands from the endogenous PTPe gene; mice which had integrated the transgene contained additional, transgene-speci®c bands.
Female transgenic and non-transgenic FVB/N mice were allowed to mate and nurse pups at will. Mice were examined visibly and, when needed, by palpitation twice weekly for presence of mammary tumors. Tumors and non-transformed tissue were excised and analysed as described below. On occasion, excised mammary tumor tissue was minced and seeded in Dulbecco's Modi®ed Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (Hyclone, Logan, Utah, USA), 4 mM glutamine, 50 units/ml penicillin G, and 50 mg/ml streptomycin. Cells from regions of distinct epithelial or spindle-like morphology were replated in separate culture dishes and cultured until uniform morphology was obtained. In some experiments, 0.5 ± 1610 6 cultured epithelial or spindle-like cells were injected in phosphatebuered saline into the¯ank or into the mammary fat pad of wild-type FVB/N female mice.
RNA and protein blot analysis
Total RNA was prepared from tissue by the guanidinium isothiocyanate-CsCl gradient technique (Chirgwin et al., 1979) . Where used, poly(A) + RNA was prepared by purifying total RNA on oligo-dT columns (mRNA Purification Kit, Pharmacia), according to the manufacturers' instructions. 10 ± 15 mg total or 1.5 mg poly (A) + RNA were run through 1% agarose gels prepared in 16MOPS buer and 0.5% formaldehyde (16MOPS buer is 20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA). RNA gels were then blotted onto GeneScreen membranes and processed as described above for DNA blots. Probes used for analysis included the full length tm-PTPe cDNA, as well as a 0.3 kb fragment of the mouse b-casein cDNA generously provided by Dr Moshe Shani (Volcani Center, Israel) and Dr Lothar Hennighausen (National Institutes of Health).
Protein was prepared from tissues by homogenization in NP40 lysis buer (50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1% Nonidet P-40). Following brief spinning down of debris, protein concentration was determined by the Bradford technique using BSA as a standard (Bradford, 1976) . Fifteen mg of proteins from each sample were analysed on a 7% SDS-polyacrylamide gel and blotted onto Immobilon-P membranes (DuPont). Blocking, hybridization with rabbit polyclonal anti-PTPe antiserum (Elson and Leder, 1995a) , and detection by enhanced chemiluminescence were done using standard protocols (Harlow and Lane, 1988) .
Whole-mount, in-situ, and histologic evaluation Mammary gland whole mounts were prepared as described (Sympson et al., 1994) . Brie¯y, the #4 (abdominal) mammary glands of mice were excised and spread on precleaned glass microscope slides and brie¯y air-dried. Glands were ®xed overnight in Tellyesniczky's ®xative (70% ethanol:formaldehyde:glacial acetic acid, 20 : 1 : 1). Following a brief rinse in water, samples were treated with acetone for 48 h and re-hydrated with a graded series of ethanol/water mixtures. Samples were then stained overnight with a fresh solution of carmine red [0.2% carmine red dye (Sigma) (w/v), 10 mM AlK(SO 4 ) 2 ], washed in water and dehydrated in a graded series of ethanol. Fat was then cleared by immersing samples in methyl salicylate.
For in-situ RNA hybridization studies, abdominal mammary glands were removed from pregnant (d14) MMTV-PTPe or control mice, spread on microscope slides, and ®xed in fresh 4% paraformaldehyde/PBS. Following removal from the slides and embedding, 6-micron sections were placed on gelatin-coated microscope slides, dewaxed, and hybridized to 35 S-labeled RNA probes overnight at 528 in a humidi®ed chamber. Hybridization, washing, and RNase treatment were performed as described in Leder et al. (1992) . Slides were dipped in emulsion (Kodak NTB-2) and exposed for a week before developing. For probe production, a 333 bp fragment of the ®rst catalytic domain of mouse PTPe was ampli®ed by PCR and cloned into pBluescript (Stratagene). Following linearization with HindIII or XhoI, sense or antisense probes were synthesized from this plasmid using T3 or T7 RNA polymerase, respectively; a-35 S-UTP was included in the reaction mix.
For histologic evaluation, tissue samples were ®xed in Optimal Fix (American Histology Reagent Company, Inc.). Four-mm sections were cut and stained with hematoxylin and eosin, and evaluated at the Transgenic Core Pathology Laboratory of the University of California at Davis.
